Loading organizations...
Key people at Time is Brain.
Time is Brain develops medical devices for real-time brain monitoring, focused on acute stroke assessment. Its core product, BraiN20, provides continuous, non-invasive brain activity tracking. This technology aids in stroke diagnosis and prognosis, offering data for timely intervention and neurological status evaluation.
Founded in Barcelona in 2020, Time is Brain was co-founded by medical experts Alicia Martínez (CEO), Antoni Dávalos (CSO), and Jaume Coll (SAB). Their deep stroke care experience and the "time is brain" principle underscored their insight: the urgent need for rapid, accurate assessment to mitigate neurological damage.
Time is Brain's solutions serve healthcare providers, including neurologists and emergency teams managing acute stroke. The company aims to improve patient outcomes via tools for faster, informed clinical decisions. Their vision is to establish a new standard in acute stroke management through continuous, non-invasive brain monitoring.
Key people at Time is Brain.
Time is Brain (TIB) is a Barcelona-based health tech startup founded in 2020 that develops BraiN20®, a portable, non-invasive medical device likened to the "stroke ECG." It monitors the brain's N20 electrical signal in real-time using AI to analyze evoked potentials from electrodes placed on the head and hands, enabling faster diagnosis and treatment of acute ischemic stroke (AIS) patients[1][2][3][5][7]. The device serves neurologists, stroke units, and emergency teams by reducing time-to-treatment from 4 hours to 1 hour, enhancing endovascular thrombectomy (EVT) efficacy, detecting complications early, and predicting recovery—addressing the crisis where every minute post-stroke kills 1.9 million brain cells[2][3][5][6]. Currently in pre-industrialization after validation in Spanish hospitals like Germans Trias i Pujol and Bellvitge, TIB has raised €1.7M, boasts a €7.9M valuation, employs 12 people, and was selected for Ship2B's health acceleration program[1][2].
TIB emerged from research initiated in 2013 by neurologists at Hospital Germans Trias i Pujol (HGTP) in Barcelona, who sought better diagnostic tools for stroke's devastating impact. A clinical study from 2018-2020 (NCT04099615) discovered and validated the N20 biomarker in AIS, leading to the company's 2020 founding by Alicia Martínez (CEO, MD PhD, neurologist with 10+ years in electrodiagnostics), Antoni Dávalos (CSO, MD PhD, renowned stroke KOL and director of Catalonia's stroke programs), and Jaume Coll i Cantí (Scientific Advisor, MD PhD)[1][3][4]. The core team includes experts like COO Blas Díaz (medtech R&D), CTO Gisela Ruiz (PhD in electrochemical biosensors), QA/RA Oriol Vernis (25+ years in medical devices), and business leads with multinational experience. Early traction came from hospital pilots validating the tech, propelling TIB toward market readiness amid regulatory hurdles[1][2][3].
Time is Brain rides the AI-driven medtech wave in stroke care, where rapid diagnostics are critical amid rising global stroke incidence (projected 200M€ market)[2]. Timing aligns with post-COVID emphasis on endovascular therapies and real-time neuromonitoring, as aging populations strain healthcare—EVT windows are narrow, and current tools lack brain-specific visibility[2][3][5]. Market tailwinds include regulatory pushes for POCT devices and HTA assessments favoring outcome-improving tech. TIB influences the ecosystem by pioneering N20 as a biomarker, potentially standardizing stroke workflows, inspiring similar AI biosensor startups, and bridging academia (HGTP research) with commercialization via accelerators like Ship2B[1][2][3].
TIB is primed for global launch post-pre-industrialization, targeting EU/CE mark then US/FDA amid active market prep (KOL dissemination, reimbursement analysis)[3]. Trends like AI personalization in neurocritical care and portable diagnostics will accelerate adoption, with pilots scaling to international trials. Influence may evolve from niche innovator to stroke standard-setter, especially if BraiN20® proves prognostic power in larger studies—embodying "Time is Brain" by turning every saved minute into lives transformed, fulfilling its originators' 2013 quest[2][3][6].
